PureCycle Technologies (PCT) is commercializing a licensed dissolution-recycling process that turns polypropylene plastic waste, commonly known as #5 plastic, into reusable resin at its Ironton, Ohio facility. Because the company is still scaling toward sustained revenue, each quarterly report is read less for its income statement than for evidence that qualified customer programs are converting into recurring shipments. I watch production volumes, commercial milestones, and monthly cash burn closely to gauge the path toward positive operating cash flow, as well as the financing runway for planned facilities in Thailand, Belgium, and Georgia. Results are also a barometer for how the company, whose technology was developed with The Procter & Gamble Company, is managing cost and regulatory timing as it pursues its commercial ramp. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, PureCycle Technologies (PCT) reported revenue of $2.3 million, down from $4.5 million in the second quarter and essentially flat versus $2.4 million a year earlier. The sequential decline reflected operational issues that limited available product, along with the extension of New Jersey's food-contact exemption, which pushed roughly 15 food-contact programs—about 50 million pounds of expected annual volume at full ramp—out of the fourth quarter.
Reported net income was $6.9 million, or $0.00 per basic and diluted share, compared with a net loss of $28.4 million in the year-ago quarter. The swing was driven by a $58.6 million non-cash gain from the change in fair value of warrants. That gain pushed the reported figure above the consensus estimate of a $0.25 per-share loss, but it does not reflect operating performance.
The operating loss narrowed modestly to $37.5 million from $38.9 million, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, adjusted for certain items) was negative $28.0 million, a $0.6 million year-over-year improvement. PureFive production totaled 5.2 million pounds, below the 7.3 million pounds produced a year earlier but up from 4.5 million pounds in the second quarter. Monthly operations spending of $7.8 million came in below the guided $8 million to $9 million range, excluding materials purchases of about $2.7 million per month.
PureCycle ended the quarter with total liquidity of $193 million, comprising $109 million in cash, $71.4 million in marketable securities, and $12.6 million in restricted cash. Including an undrawn $200 million revolving credit facility, total available liquidity was $393 million.
Because PureCycle Technologies (PCT) is a low-revenue, pre-profitability company, the stock's reaction to earnings tends to hinge less on top-line totals and more on the narrative around commercialization. The third-quarter update offered a mixed picture: a revenue miss and a New Jersey-driven delay in food-contact programs weighed on near-term volume visibility, while better-than-guided cost control, a recovering production run-rate, and a healthy liquidity position provided offsets. Investor sentiment is therefore likely to remain anchored to how quickly qualified brand programs—such as hot lids, deodorant sticks, and quick-service restaurant cups—convert into recurring purchase orders, rather than to short-term earnings per share, which remains distorted by non-cash warrant accounting. From what I see, this balance of operational progress and external delays will likely shape near-term moves.
Several factors warrant monitoring following this report. First, management indicated that branded programs shipping, under purchase order, or in final qualification represent roughly 45 to 55 million pounds of annual volume at full ramp, approaching 40 to 50% utilization at Ironton. Confirming that these programs begin converting into recurring shipments during the fourth quarter and early 2027 will be the clearest signal of commercial traction.
Second, cost discipline matters for the runway. Monthly operations spending of $7.8 million was below guidance, and management plans additional reductions in the fourth quarter of 2026 and first quarter of 2027, including greater use of in-house maintenance, consolidated roles, and an on-site nitrogen supply in 2027.
Third, financing and expansion milestones remain key. The company expects fourth-quarter project spending of about $4 million, excluding Thailand financing, and is working through final terms for that project's financing. Progress on planned facilities in Thailand, Belgium (Antwerp), and Georgia (Augusta) will shape the longer-term capacity story.
Finally, regulatory and customer timelines remain a source of uncertainty. The New Jersey food-contact exemption extension deferred roughly 15 programs out of the fourth quarter, and some brand conversions continue on their own timetables. Investors will be watching whether those deferrals prove temporary or signal more durable delays to the ramp. I’m watching this closely as the company works through these variables.
In my own analysis, I frequently rely on Tickeron’s AI Screener to filter opportunities across sectors and compare names like PureCycle Technologies (PCT) against peers using technical patterns, fundamentals, and AI-driven signals. This helps surface relevant ideas efficiently when tracking commercialization stories in the recycling space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for PCT moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 42 similar instances when the indicator left oversold territory. In 37 of the 42 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on PCT as a result. In 72 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for PCT just turned positive on October 27, 2026. Looking at past instances where PCT's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
Following a +5.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where PCT advanced for three days, in 196 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
PCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for PCT entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. PCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PCT's P/B Ratio (36.158) is slightly higher than the industry average of (11.776). P/E Ratio (-2.082) is within average values for comparable stocks, (-17.204). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.975). Dividend Yield (0.000) settles around the average of (0.057) among similar stocks. P/S Ratio (72.993) is also within normal values, averaging (251.106).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialSpecialties